Pfizer Inc. (PFE)
Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation (Buy)
Pfizer Obesity Hype And Vaccine Policy Shocks (Sell)
Pfizer's Portfolio Renewal In Progress - High Yields For The Patient (Buy)
Pfizer's Quiet Cash Comeback (Buy)
Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game (Buy)
(Earnings Call Insights) Pfizer outlines $150B obesity market strategy as VESPER-3 data supports monthly GLP-1 approach
Pfizer： A High-Yield Pharma At A Turning Point (StrongBuy)
Pfizer_The Market Is Still Wrong About It (Buy)
Pfizer_The Patent Cloud Is An Opportunity For Bargain Hunters (StrongBuy)
Pfizer_Is This Pharma Giant Finally A Bargain (StrongBuy)
Pfizer's Rich Dividend Story Meets Overpriced Metsera Acquisition/Patent Cliff Risks (Buy)
Pfizer Strengthens Pipeline With $10B Metsera Deal Amid Solid Q3 Results (Buy)
